Comprehensive Review of Small Cell Lung Carcinoma (SCLC): Pathophysiology, Diagnosis, and Management – A Clinician’s Guide with Evidence-Based Insights
Updated with Current Evidence-Based Guidelines (2023–2024) Epidemiology and Pathobiological Context Small cell lung carcinoma (SCLC) accounts for approximately 13–15% of all primary lung cancers, with an incidence declining modestly over the past two decades—largely reflecting reduced smoking prevalence—but remains one of the most aggressive malignancies encountered in clinical oncology. Median age at diagnosis is ~65…
